Ovid develops small molecule medicines for brain disorders such as epilepsy, seizure disorders and psychosis. It last closed at $2.20 on Nov 20, down 5.98% on the day. The next earnings report for OVID is expected around Wed, Mar 17, 2027. Over its last 8 reports the stock moved an average of 4.3% the session after earnings. Over the last 12 months OVID insiders bought $0 of stock on the open market and sold $29K, according to SEC Form 4 filings.
AI Auto Pilots
Is OVID in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold OVID.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on OVIDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
OVID · as of the Nov 20 close · updated each morning
Turning down
The stock is 13% below its 20 day and 12% below its 50 day average. It is 11% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 41). The nearest support is the swing low (Jun 23) at $2.19, and the nearest resistance the Pivot at $2.23.
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 9.8%/day
Key levels
$3.1052 week high+40.9%
$2.54100 day average+15.5%
$2.4920 day average+13.2%
$2.49Swing high (Oct 12)+13.2%
$2.4650 day average+11.8%
$2.43200 day average+10.5%
$2.29Pivot R1+4.1%
$2.23Pivot+1.4%
$2.20Last close
$2.19Swing low (Jun 23)−0.5%
$2.14Pivot S1−2.7%
$1.2152 week low−45.0%
Indicators
RSI (14)
40.73
Middle of its range
Neutral
MACD
-0.04
Below its signal line
Bearish
Stochastic
11.5
Near the bottom of its range
Oversold
ADX (14)
18.1
No clear trend
Williams %R
-95.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-98.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−22.8%
Change over 10 sessions
Bearish
ATR (14)
$0.22
Typical daily range, 9.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 18.2%/day
Key levels
$3.1052 week high+40.9%
$2.54100 day average+15.5%
$2.4920 day average+13.2%
$2.49Swing high (Oct 12)+13.2%
$2.4650 day average+11.8%
$2.43200 day average+10.5%
$2.29Pivot R1+4.1%
$2.23Pivot+1.4%
$2.20Last close
$2.19Swing low (Jun 23)−0.5%
$2.14Pivot S1−2.7%
$1.2152 week low−45.0%
Indicators
RSI (14)
45.11
Middle of its range
Neutral
MACD
0.03
Below its signal line
Bearish
Stochastic
48.1
Middle of its range
Neutral
ADX (14)
22.5
Weak trend
Williams %R
-89.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-84.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−18.2%
Change over 10 sessions
Bearish
ATR (14)
$0.40
Typical daily range, 18.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for OVID
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OVID did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow OVID usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for OVIDHow many large options trades hit OVID, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in OVID in the last 90 days.
From SEC Form 4 filings by OVID's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OVID is in one of them and how their past OVID trades turned out.
Ovid is a biopharmaceutical company that develops small molecule medicines for disorders of the brain and nervous system. Its work centers on epilepsy, seizure disorders and psychosis, with medicines designed to calm overactive nerve cells. Its programs are in clinical trials, and the company aims to serve patients with seizure and psychiatric conditions that have few treatment options. Ovid is based in New York.